The Management of Cytokine Storm in COVID-19

Cleopas Martin Rumende, Erwin C. Susanto, Truely P. Sitorus

Research output: Contribution to journalReview articlepeer-review

Abstract

Cytokine storm in COVID-19 infection is an excessive immune response to external stimuli where the pathogenesis is complex. The disease progresses rapidly and the mortality is high. Certain evidence shows that the severe deterioration of some patients has been closely related to the strong upregulation of cytokine production in SARS-Co-V2 induced pneumonia with an associated cytokine storm syndrome. Identification of existing approaved therapy with proven safety profile to treat hyperinflammation is critical unmet need in order to reduce COVID-19 associated mortality. To date, no specific therapeutic drugs are available to treat COVID-19 infection. Preliminary studies have shown that immune-modulatory or immune suppressive treatments might be considered as treatment choices for COVID-19, particularly in severe disease. This article review the pathogenesis and treatment strategies of COVID-19 virus-induced inflammatory storm in attempt to provide valuable medication guidance for clinical treatment.

Original languageEnglish
Pages (from-to)306-313
Number of pages8
JournalActa medica Indonesiana
Volume52
Issue number3
Publication statusPublished - 1 Jul 2020

Keywords

  • COVID-19
  • cytokine storm
  • hyperinflammation

Fingerprint Dive into the research topics of 'The Management of Cytokine Storm in COVID-19'. Together they form a unique fingerprint.

Cite this